Flashblood: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== | {{Infobox medical condition | ||
[[ | | name = Flashblood | ||
| image = <!-- Image removed --> | |||
| caption = <!-- Caption removed --> | |||
| field = [[Addiction medicine]] | |||
| symptoms = [[Euphoria]], [[drowsiness]], [[nausea]], [[vomiting]], [[respiratory depression]] | |||
| complications = [[HIV/AIDS]], [[hepatitis]], [[overdose]] | |||
| onset = Immediate | |||
| duration = Short-term | |||
| causes = [[Intravenous drug use]] | |||
| risks = [[Bloodborne infections]] | |||
| prevention = [[Harm reduction]], [[needle exchange programs]] | |||
| treatment = [[Addiction treatment]], [[antiretroviral therapy]] | |||
}} | |||
'''Flashblood''' is a high-risk practice associated with [[intravenous drug use]], particularly among users of [[heroin]] and other [[opioids]]. It involves the withdrawal of blood from a person who has recently injected drugs and the subsequent injection of that blood into another person. This practice is primarily reported in regions with limited access to drugs and is driven by the desire to experience the [[euphoria]] associated with the drug. | |||
== | == Mechanism == | ||
Flashblood involves the transfer of blood that contains residual amounts of the drug. The recipient injects this blood in an attempt to achieve a similar [[psychoactive]] effect. However, the concentration of the drug in the blood is significantly lower than in a direct injection, leading to a reduced effect. | |||
== Health Risks == | |||
The practice of flashblood carries significant health risks, primarily due to the potential transmission of [[bloodborne infections]] such as [[HIV/AIDS]] and [[hepatitis]]. The sharing of needles and blood increases the likelihood of spreading these infections among users. Additionally, there is a risk of [[overdose]] if the concentration of the drug in the blood is underestimated. | |||
==Prevention and | == Prevention and Harm Reduction == | ||
Efforts to | Efforts to reduce the practice of flashblood focus on [[harm reduction]] strategies. These include the implementation of [[needle exchange programs]] and education on the risks associated with sharing needles and blood. Providing access to [[addiction treatment]] and [[antiretroviral therapy]] for those at risk of or living with HIV/AIDS is also crucial. | ||
== See Also == | |||
* [[Intravenous drug use]] | |||
* [[Harm reduction]] | |||
* [[Bloodborne infections]] | |||
== | == References == | ||
{{Reflist}} | |||
== | == External Links == | ||
* [Harm Reduction Coalition](https://harmreduction.org/) | |||
* [World Health Organization: HIV/AIDS](https://www.who.int/hiv/en/) | |||
[[Category:Addiction]] | |||
[[Category:Drug culture]] | [[Category:Drug culture]] | ||
[[Category: | [[Category:Bloodborne diseases]] | ||
[[Category: | [[Category:Public health]] | ||
Latest revision as of 17:31, 30 December 2024
| Flashblood | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Euphoria, drowsiness, nausea, vomiting, respiratory depression |
| Complications | HIV/AIDS, hepatitis, overdose |
| Onset | Immediate |
| Duration | Short-term |
| Types | N/A |
| Causes | Intravenous drug use |
| Risks | Bloodborne infections |
| Diagnosis | N/A |
| Differential diagnosis | N/A |
| Prevention | Harm reduction, needle exchange programs |
| Treatment | Addiction treatment, antiretroviral therapy |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | N/A |
| Deaths | N/A |
Flashblood is a high-risk practice associated with intravenous drug use, particularly among users of heroin and other opioids. It involves the withdrawal of blood from a person who has recently injected drugs and the subsequent injection of that blood into another person. This practice is primarily reported in regions with limited access to drugs and is driven by the desire to experience the euphoria associated with the drug.
Mechanism[edit]
Flashblood involves the transfer of blood that contains residual amounts of the drug. The recipient injects this blood in an attempt to achieve a similar psychoactive effect. However, the concentration of the drug in the blood is significantly lower than in a direct injection, leading to a reduced effect.
Health Risks[edit]
The practice of flashblood carries significant health risks, primarily due to the potential transmission of bloodborne infections such as HIV/AIDS and hepatitis. The sharing of needles and blood increases the likelihood of spreading these infections among users. Additionally, there is a risk of overdose if the concentration of the drug in the blood is underestimated.
Prevention and Harm Reduction[edit]
Efforts to reduce the practice of flashblood focus on harm reduction strategies. These include the implementation of needle exchange programs and education on the risks associated with sharing needles and blood. Providing access to addiction treatment and antiretroviral therapy for those at risk of or living with HIV/AIDS is also crucial.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
- [Harm Reduction Coalition](https://harmreduction.org/)
- [World Health Organization: HIV/AIDS](https://www.who.int/hiv/en/)